- Previous Close
3,040.00 - Open
2,970.00 - Bid 3,035.00 x --
- Ask 3,100.00 x --
- Day's Range
2,970.00 - 3,130.00 - 52 Week Range
2,970.00 - 9,300.00 - Volume
18,606 - Avg. Volume
21,518 - Market Cap (intraday)
36.436B - Beta (5Y Monthly) 0.65
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 14, 2025 - May 19, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.
www.telcon.co.kr--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 200230.KQ
View MorePerformance Overview: 200230.KQ
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 200230.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 200230.KQ
View MoreValuation Measures
Market Cap
36.44B
Enterprise Value
82.09B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.95
Price/Book (mrq)
0.44
Enterprise Value/Revenue
2.17
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-69.51%
Return on Assets (ttm)
-0.03%
Return on Equity (ttm)
-28.18%
Revenue (ttm)
37.87B
Net Income Avi to Common (ttm)
-26.32B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
10.04B
Total Debt/Equity (mrq)
66.99%
Levered Free Cash Flow (ttm)
10.35B